Log in

Akerna Stock Forecast, Price & News

+0.45 (+13.04 %)
(As of 11/27/2020 12:00 AM ET)
Today's Range
Now: $3.90
50-Day Range
MA: $3.48
52-Week Range
Now: $3.90
Volume2.47 million shs
Average Volume449,847 shs
Market Capitalization$76.78 million
P/E RatioN/A
Dividend YieldN/A
Akerna Corp. operates as a technology company. The company offers MJ Platform, an enterprise resource planning system to the cannabis industry; and Leaf Data Systems, a tracking system designed for government agencies. It also provides consulting services to cannabis industry; business intelligence, an infrastructure as a service tool, which delivers supply chain analytics for the cannabis, hemp, and CBD industries; and Last Call Analytics, a subscription analytics tool for alcohol brands to analyze their retail sales analytics. In addition, the company operates seed-to-sale platform that allows cultivators to track and report various stage of their cannabis growing operations, production, and sales processes. Further, it offers cannabis cultivation management and software to manage and optimize operational workflow in business analytics; and cannabis tracking technology that provides seed-to-sale-to-self data. Akerna Corp. was founded in 2010 and is headquartered in Denver, Colorado.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 3.5Community Rank: 3.4Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.38 out of 5 stars

Industry, Sector and Symbol

Industry Data processing & preparation
Current SymbolNASDAQ:KERN



Sales & Book Value

Annual Sales$12.57 million
Book Value$2.76 per share


Net Income$-15,530,000.00
Net Margins-137.11%


Market Cap$76.78 million
Next Earnings Date2/10/2021 (Estimated)
OptionableNot Optionable
+0.45 (+13.04 %)
(As of 11/27/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive KERN News and Ratings via Email

Sign-up to receive the latest news and ratings for KERN and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

Akerna (NASDAQ:KERN) Frequently Asked Questions

How has Akerna's stock been impacted by Coronavirus (COVID-19)?

Akerna's stock was trading at $6.12 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, KERN stock has decreased by 36.3% and is now trading at $3.90.
View which stocks have been most impacted by COVID-19

Do Wall Street analysts recommend investors buy shares of Akerna?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Akerna in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Akerna

What stocks does MarketBeat like better than Akerna?

Wall Street analysts have given Akerna a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's winning trading ideas this year have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Akerna wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is Akerna's next earnings date?

Akerna is scheduled to release its next quarterly earnings announcement on Wednesday, February 10th 2021.
View our earnings forecast for Akerna

How were Akerna's earnings last quarter?

Akerna Corp. (NASDAQ:KERN) posted its quarterly earnings results on Tuesday, November, 17th. The company reported ($0.42) earnings per share (EPS) for the quarter, missing the Thomson Reuters' consensus estimate of ($0.28) by $0.14. Akerna had a negative return on equity of 58.33% and a negative net margin of 137.11%.
View Akerna's earnings history

What price target have analysts set for KERN?

1 Wall Street analysts have issued twelve-month price objectives for Akerna's stock. Their forecasts range from $8.00 to $8.00. On average, they expect Akerna's share price to reach $8.00 in the next twelve months. This suggests a possible upside of 105.1% from the stock's current price.
View analysts' price targets for Akerna

Are investors shorting Akerna?

Akerna saw a increase in short interest during the month of October. As of October 30th, there was short interest totaling 1,040,000 shares, an increase of 77.4% from the October 15th total of 586,200 shares. Based on an average trading volume of 924,400 shares, the short-interest ratio is presently 1.1 days. Currently, 13.6% of the shares of the stock are sold short.
View Akerna's Short Interest

Who are some of Akerna's key competitors?

What other stocks do shareholders of Akerna own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Akerna investors own include KushCo (KSHB), OrganiGram (OGI), The Supreme Cannabis (SPRWF), Auxly Cannabis Group (CBWTF), Charlotte's Web (CWBHF), Medical Marijuana (MJNA), MariMed (MRMD), Matinas BioPharma (MTNB), Cannabics Pharmaceuticals (CNBX) and DHT (DHT).

Who are Akerna's key executives?

Akerna's management team includes the following people:
  • Ms. Jessica Billingsley, Chairman & CEO (Age 43, Pay $326.53k)
  • Mr. John Michael Fowle Jr., CFO & Sec. (Age 42, Pay $196.67k)
  • Mr. Scott Sozio, Head of Corp. Devel. & Director (Age 40, Pay $234.27k)
  • Ms. Nina Simosko, Chief Commercial Officer (Age 52, Pay $200.14k)
  • Mr. Cecil Ray Thompson Jr., Chief Operating Officer (Age 50)
  • Mr. Ashesh C. Shah, Pres of Solo Sciences (Age 50)
  • Mr. David R. McCullough, Chief Technology Officer (Age 44)

What is Akerna's stock symbol?

Akerna trades on the NASDAQ under the ticker symbol "KERN."

Who are Akerna's major shareholders?

Akerna's stock is owned by a number of institutional and retail investors. Top institutional shareholders include Creative Planning (2.51%), State Street Corp (0.73%), AdvisorShares Investments LLC (0.15%), LPL Financial LLC (0.09%) and Apollon Wealth Management LLC (0.07%). Company insiders that own Akerna stock include Amy A Poinsett Revocable Livi and Jessica Billingsley.
View institutional ownership trends for Akerna

Which institutional investors are buying Akerna stock?

KERN stock was purchased by a variety of institutional investors in the last quarter, including Creative Planning, AdvisorShares Investments LLC, State Street Corp, LPL Financial LLC, and Apollon Wealth Management LLC.
View insider buying and selling activity for Akerna

How do I buy shares of Akerna?

Shares of KERN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Akerna's stock price today?

One share of KERN stock can currently be purchased for approximately $3.90.

How big of a company is Akerna?

Akerna has a market capitalization of $76.78 million and generates $12.57 million in revenue each year. Akerna employs 136 workers across the globe.

What is Akerna's official website?

The official website for Akerna is www.akerna.com.

How can I contact Akerna?

Akerna's mailing address is 1601 ARAPAHOE STREET, DENVER CO, 80202. The company can be reached via phone at 888-932-6537 or via email at [email protected]

This page was last updated on 11/28/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.